Cargando…
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
BACKGROUND: There are currently no biomarkers for early breast cancer patient populations at risk of bone metastasis. Identification of mediators of bone metastasis could be of clinical interest. METHODS: A de novo unbiased screening approach based on selection of highly bone metastatic breast cance...
Autores principales: | Pavlovic, Milica, Arnal-Estapé, Anna, Rojo, Federico, Bellmunt, Anna, Tarragona, Maria, Guiu, Marc, Planet, Evarist, Garcia-Albéniz, Xabier, Morales, Mónica, Urosevic, Jelena, Gawrzak, Sylwia, Rovira, Ana, Prat, Aleix, Nonell, Lara, Lluch, Ana, Jean-Mairet, Joël, Coleman, Robert, Albanell, Joan, Gomis, Roger R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681582/ https://www.ncbi.nlm.nih.gov/pubmed/26376684 http://dx.doi.org/10.1093/jnci/djv256 |
Ejemplares similares
-
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
por: Slebe, Felipe, et al.
Publicado: (2016) -
RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation
por: Morales, Mònica, et al.
Publicado: (2014) -
Tumor cell dormancy
por: Gomis, Roger R., et al.
Publicado: (2017) -
BRAF(V600E) Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
por: Soria, Xavier, et al.
Publicado: (2021) -
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice
por: Paterson, Alexander H G, et al.
Publicado: (2021)